The Biden administration has stopped a Baltimore manufacturing plant from making AstraZeneca s COVID vaccine after it ruined 15 million doses of Johnson & Johnson s.
2 weeks ago in Local Photo: WHMP
(Undated) – Massachusetts was on track to receive more than 100,000 doses of the one-shot Johnson & Johnson COVID-19 vaccine next week. Gov. Charlie Baker said Wednesday that the extra 100,000 doses will let more Massachusetts residents get fully vaccinated faster than those who receive the Moderna and Pfizer vaccines. But hours later came word that workers at Emergent BioSolutions’ Baltimore plant accidentally spoiled about 15 million doses of the J and J vaccine several weeks ago. The Massachusetts COVID Command Center says news of the spoiled J and J vaccines does not impact current appointments in this state.
Global stocks higher…Problems with J&J supplier
BEIJING (AP) Global stock markets have followed Wall Street higher after Japan and South Korea reported unexpectedly strong economic data and President Joe Biden announced a $2.3 trillion infrastructure spending plan. In early trading, the FTSE 100 in London rose 0.6%, the DAX in Frankfurt added 0.5% and the CAC 40 in Paris gained 0.2%. In Asian markets, the Shanghai Composite Index closed 0.7% higher, the Nikkei 225 in Tokyo advanced 0.7% and the Hang Seng in Hong Kong climbed 1.9%. On Wall Street, Dow and S&P futures are both higher.
WASHINGTON (AP) Congressional committees were laying the groundwork for a major public works investment even before President Joe Biden unveiled his $2.3 trillion infrastructure plan. They’ve been holding hearings to listen to experts in the field and top-ranking administration officials and introducing scores of bills. And now the hard part begins, cobbling together something that can pass such
Company at heart of J&J COVID vaccine woes has series of citations
Johnson & Johnson said Wednesday a batch of vaccine made by Emergent BioSolutons can t be used because it didn t meet quality standards. Author: RICHARD LARDNER and LINDA JOHNSON Associated Press Published: 1:02 AM EDT April 1, 2021 Updated: 1:02 AM EDT April 1, 2021
The company at the center of quality problems that led Johnson & Johnson to discard an unknown amount of its coronavirus vaccine has a string of citations from U.S. health officials for quality control problems.
Emergent BioSolutons, a little-known company at the center of the vaccine supply chain, was a key to Johnson & Johnson s plan to deliver 100 million doses of its vaccine to the U.S. by the end of May. But the company has been cited repeatedly by the Food and Drug Administration for problems such as poorly trained employees, cracked vials and mold around one of its facilities, according to
15 million Johnson & Johnson COVID vaccine doses discarded kagstv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kagstv.com Daily Mail and Mail on Sunday newspapers.